These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36713976)

  • 1. Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia.
    Aomar-Millán IF; Fatoul-Del Pino G; Torres-Parejo Ú; Pérez Fernández L; Martínez-Diz S; Salvatierra J
    Med Clin (Engl Ed); 2023 Feb; 160(4):156-159. PubMed ID: 36713976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia.
    Aomar-Millán IF; Fatoul-Del Pino G; Torres-Parejo Ú; Pérez-Fernández L; Martínez-Diz S; Salvatierra J
    Med Clin (Barc); 2023 Feb; 160(4):156-159. PubMed ID: 35987733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia.
    Pinzón MA; Ortiz S; Holguín H; Betancur JF; Cardona Arango D; Laniado H; Arias Arias C; Muñoz B; Quiceno J; Jaramillo D; Ramirez Z
    PLoS One; 2021; 16(5):e0252057. PubMed ID: 34033648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients.
    Saeed MAM; Mohamed AH; Owaynat AH
    Egypt J Intern Med; 2022; 34(1):19. PubMed ID: 35194371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pulse methylprednisolone on prognosis in SARS-CoV-2 patients with severe pneumonia.
    Eraslan BZ; Fidan A; Baysal T; Cömert SS; Kıral N; Parmaksız ET
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):1234-1240. PubMed ID: 38375729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose pulse methylprednisolone vs. dexamethasone standard therapy for severe and critical COVID-19 pneumonia: Efficacy assessment in a retrospective single-centre experience from Malaysia.
    Soo CI; Poon KV; Ayub A; You HW; Tan CX; Loh KJJ; Eng CCH; Sia LC; Wong CK
    Med J Malaysia; 2024 Jan; 79(1):15-20. PubMed ID: 38287752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study.
    Aljuhani O; Korayem GB; Altebainawi AF; AlMohammady D; Alfahed A; Altebainawi EF; Aldhaeefi M; Badreldin HA; Vishwakarma R; Almutairi FE; Alenazi AA; Alsulaiman T; Alqahtani RA; Al Dhahri F; Aldardeer N; Alenazi AO; Al Harbi S; Kensara R; Alalawi M; Al Sulaiman K
    BMC Infect Dis; 2024 Feb; 24(1):189. PubMed ID: 38350878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study.
    Landolfo M; Maino A; Di Salvo E; Fiorini G; Peterlana D; Borghi C
    Intern Emerg Med; 2022 Aug; 17(5):1335-1341. PubMed ID: 35064437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged higher dose methylprednisolone
    Salton F; Confalonieri P; Centanni S; Mondoni M; Petrosillo N; Bonfanti P; Lapadula G; Lacedonia D; Voza A; Carpenè N; Montico M; Reccardini N; Meduri GU; Ruaro B; ; Confalonieri M; ; Citton GM; Lapadula G; Bozzi C; Tavano S; Pozzan R; Andrisano AG; Jaber M; Mari M; Trotta L; Mondini L; Barbieri M; Ruggero L; Antonaglia C; Soave S; Torregiani C; Bogatec T; Baccelli A; Nalesso G; Re B; Pavesi S; Barbaro MPF; Giuliani A; Ravaglia C; Poletti V; Scala R; Guidelli L; Golfi N; Vianello A; Achille A; Lucernoni P; Gaccione AT; Romagnoli M; Fraccaro A; Malacchini N; Malerba M; Ragnoli B; Zamparelli AS; Bocchino M; Blasi F; Spotti M; Miele C; Piedepalumbo F; Barone I; Baglioni S; Dodaj M; Franco C; Andrani F; Mangia A; Mancini A; Carrozzi L; Rafanelli A; Casto E; Rogliani P; Ora J; Carpagnano GE; Di Lecce V; Tamburrini M; Papi A; Contoli M; Luzzati R; Zatta M; Di Bella S; Caraffa E; Francisci D; Tosti A; Pallotto C; De Rosa FG; Pecori A; Franceschini M; Carlin M; Orsini V; Spolti A; Inannace M; Santantonio T; Meli R; Sauro S; Fedeli C; Mangini E; Biolo G; Nunnari A; Pietrangelo A; Corradini E; Bocchi D; Boarini C; Zucchetto A; Lanini S
    Eur Respir J; 2023 Apr; 61(4):. PubMed ID: 36356972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
    Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M
    Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Dose Methylprednisolone Pulses for 3 Days vs. Low-Dose Dexamethasone for 10 Days in Severe, Non-Critical COVID-19: A Retrospective Propensity Score Matched Analysis.
    Mora-Luján JM; Tuells M; Montero A; Formiga F; Homs NA; Albà-Albalate J; Corbella X; Rubio-Rivas M
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy of dexamethasone and methylprednisolone in moderate to severe covid 19 disease.
    Fatima SA; Asif M; Khan KA; Siddique N; Khan AZ
    Ann Med Surg (Lond); 2020 Dec; 60():413-416. PubMed ID: 33200031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.
    Grasselli G; Zanella A; Carlesso E; Florio G; Canakoglu A; Bellani G; Bottino N; Cabrini L; Castelli GP; Catena E; Cecconi M; Cereda D; Chiumello D; Forastieri A; Foti G; Gemma M; Giudici R; Grazioli L; Lombardo A; Lorini FL; Madotto F; Mantovani A; Mistraletti G; Mojoli F; Mongodi S; Monti G; Muttini S; Piva S; Protti A; Rasulo F; Scandroglio AM; Severgnini P; Storti E; Fumagalli R; Pesenti A;
    JAMA Netw Open; 2022 Oct; 5(10):e2238871. PubMed ID: 36301541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of equivalent doses of dexamethasone, methylprednisolone, and hydrocortisone for treatment of COVID-19-related acute respiratory distress syndrome: a prospective three-arm randomized clinical trial.
    Taher A; Lashkari M; Keramat F; Hashemi SH; Sedighi L; Poorolajal J; Mehrpooya M
    Wien Med Wochenschr; 2023 Apr; 173(5-6):140-151. PubMed ID: 36624180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19.
    Abbasian L; Toroghi N; Rahmani H; Khalili H; Hasannezhad M; Ghiasvand F; Jafari S; Salehi M; Salahshour F; Azadbakhsh Kanaf Gorabi M; Alizade F; Ghaderkhani S; Nakhostin M
    Int Immunopharmacol; 2022 Jun; 107():108689. PubMed ID: 35313272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between different corticosteroid regimens used in severe SARS-CoV-2 infection and short-term mortality: retrospective cohort study.
    González-Castro A; Fernandez A; Cuenca-Fito E; Peñasco Y; Ceña J; Rodríguez Borregán JC
    Rev Esp Anestesiol Reanim (Engl Ed); 2024 May; 71(5):379-386. PubMed ID: 38395302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients With COVID-19.
    Ko JJ; Wu C; Mehta N; Wald-Dickler N; Yang W; Qiao R
    J Intensive Care Med; 2021 Jun; 36(6):673-680. PubMed ID: 33632000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulse Methylprednisolone Versus Dexamethasone in COVID-19: A Multicenter Cohort Study.
    Watanabe A; Inokuchi R; Kuno T; Uda K; Komiyama J; Adomi M; Ishisaka Y; Abe T; Tamiya N; Iwagami M
    Crit Care Explor; 2023 Apr; 5(4):e0886. PubMed ID: 36998527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia.
    Batule S; Soldevila B; Figueredo C; Julián MT; Egea-Cortés L; Reyes-Ureña J; Casabona J; Mateu L; Paredes R; Clotet B; López R; Puig-Domingo M; Alonso N
    Front Endocrinol (Lausanne); 2022; 13():1009028. PubMed ID: 36619546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methylprednisolone pulse vs conventional dexamethasone for adult cases of COVID-19 requiring oxygen; a Japanese retrospective cohort study.
    Watanabe Y; Nakamura I; Sato S; Fujita H; Kobayashi T; Watanabe H
    J Infect Chemother; 2023 Mar; 29(3):269-273. PubMed ID: 36436740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.